Aurinia Pharmaceuticals Inc (AUPH)
AUPH trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$16.36
-1.15% on the day
Market cap
$2.2B
Mid cap
Revenue · 2025
$283.1M
+20.4% on 2024
Net income · 2025
$287.2M
101.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AUPH on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001600620 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | ALBERTA, CANADA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $283.1M |
| Net income | $287.2M |
| Operating income | $104.9M |
| Net margin | 101.5% |
| Operating margin | 37.1% |
| Revenue growth | +20.4% |
| Cash | $80.2M |
| Total assets | $751.6M |
| P/E (computed) | 7.6× |
| P/S (computed) | 7.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2021-11-19 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-19 |
| Latest proxy | DEF 14A | 2026-04-21 |
Source: SEC EDGAR submissions feed, 613 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +3.6% |
| 1 month | +2.9% |
| 3 months | +4.1% |
| Year to date | +4.0% |
| 1 year | +49.5% |
| From 52-week high | -10.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IRON | Disc Medicine Inc. | $56.60 | -6.42% | $2.2B |
| HRMY | Harmony Biosciences Holdings Inc. | $37.03 | -3.14% | $2.2B |
| BHC | Bausch Health Companies Inc. | $5.89 | -0.68% | $2.2B |
| PRGO | Perrigo Company plc | $15.37 | -0.52% | $2.1B |
| PHVS | Pharvaris N.V. | $30.02 | -2.82% | $2.1B |
| IMNM | Immunome Inc. | $17.58 | -8.20% | $2.1B |
| VRDN | Viridian Therapeutics Inc. | $18.22 | -0.44% | $2.1B |
| NRIX | Nurix Therapeutics Inc. | $22.13 | -0.14% | $2.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier